What is Injectafer?

Injectafer is a prescription iron replacement medicine used for the treatment of iron deficiency anemia (IDA) in adults and children 1 year of age and older who cannot tolerate iron taken by mouth (oral) or who have not responded well to oral iron or adults who have chronic kidney disease who are not on dialysis (non-dialysis-dependent chronic kidney disease)

Injectafer is also used for the treatment of iron deficiency in adults with mild to moderate heart failure to improve the ability to exercise (improve exercise capacity).

For savings & support, call 1-877-448-4766
Open menu
Open menu MENU
Open menu MENU

For savings & support, call 1-888-437-4669

SUPPORT AND SAVINGS

Injectafer Patient support

If you have an Injectafer prescription, you may be able to get help with your out-of-pocket costs.

The Injectafer Savings Program*

Dollar sign icon

For eligible patients

  • Assistance of up to $500 per dose
  • Enrollment is valid for 2 courses of treatment per 12-month period

Patients may pay as little as

$50†

per dose

*The Injectafer Savings Program is only available for patients who are commercially insured. Please see full Terms and Conditions.

†Insurance out-of-pocket payment must be over $50. Other restrictions may apply.

ARE YOU ELIGIBLE?

You may be eligible if:

  • You have commercial insurance and you are a resident of the USA or its territories, including Puerto Rico

You are NOT eligible if:

  • You have Medicare, Medicaid, or other federal or state healthcare insurance OR you have private indemnity or HMO insurance that reimburses patients for the entire cost of prescription drugs
  • You are Medicare-eligible and enrolled in an employer-sponsored health plan or medical or prescription drug benefit program for retirees

To see if you're eligible, visit injectafercopay.com or call 1-877-448-4766.

Restrictions apply.

HOW TO GET YOUR SAVINGS

Ask your healthcare professional to enroll you. They will need the last 4 digits of your Social Security number to confirm whether you are eligible.

If your healthcare professional cannot enroll you, you can enroll yourself in one of two ways:

Once you're enrolled and receive your infusion of Injectafer, your healthcare professional will bill the Injectafer Savings Program for your co-pay requirement.

If the co-pay requirement is more than $500 for your infusion, your healthcare professional may bill you for the remaining amount that you'll need to pay.

If your healthcare professional requires you to pay the co-pay when you receive your infusion, the Injectafer Savings Program will reimburse you via paper check. To do this, you will need a Check Request Form. The best place to get the form is online at Injectafercopay.com. If you have any questions throughout the process, please call AR Assist (1-877-448-4766).

  • Website Injectafercopay.com OR
  • Phone: 1-877-448-4766
  • Fax: 1-888-257-4673
  • Mail: Injectafer Savings Program
    PO Box 2355
    Morristown, NJ 07962

Enrolling Yourself?

Call or enroll online

To determine whether you are eligible for the program and to enroll, you can:

Qualifying patients are usually enrolled within a few minutes. Upon completion of the enrollment process, an Injectafer Savings Program virtual debit card number will be issued to you. You will receive a welcome letter in the mail, and your healthcare professional's office will receive a fax confirming your enrollment.

Download the Injectafer savings program brochure

Injectafer Savings Program Terms and Conditions

  1. This offer is valid for commercially insured patients. Uninsured and cash-paying patients are NOT eligible for this Program.
  2. Depending on insurance coverage, eligible patients may pay no more than $50 per dose for up to four doses per calendar year. There is a maximum savings limit of $500 per dose, with an overall program limit of $2,000 per calendar year. Check with your pharmacist or healthcare professional for your co-pay discount. Patient out-of-pocket expense may vary.
  3. This offer is not valid for patients enrolled in Medicare Part B or Medicare Part D, Medicaid, or other federal or state healthcare programs, or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. Patients may not use this card if they are Medicare-eligible and enrolled in an employer-sponsored health plan or medical or prescription drug benefit program for retirees.
  4. An explanation of benefits (EOB) statement must be faxed, uploaded in the portal, or mailed in prior to transacting on the account numbers for co-pay assistance.
  5. Offer is invalid for claims or transactions more than 180 days from the date on the EOB.
  6. Patients will be automatically re-enrolled in the next calendar year. If there is no co-pay claim activity for 18 months, the enrollment will be canceled.
  7. American Regent, Inc. reserves the right to rescind, revoke, or amend this offer without notice. Offer good only in the USA, including Puerto Rico, at participating pharmacies or healthcare professionals.
  8. Void if prohibited by law, taxed, or restricted.
  9. This account number is not transferable. The selling, purchasing, trading, or counterfeiting of this account number is prohibited by law.
  10. This account number is not insurance.
  11. By redeeming this account number, you acknowledge that you are an eligible patient and that you understand and agree to comply with the terms and conditions of this offer.
  12. Qualified patients receiving Injectafer will be allowed a 180-day retroactive enrollment period from the date of EOB (eligibility of benefit form) to receive benefits under the program rules.

Downloadable resource

If you have an Injectafer prescription, you may be able to get help with your out-of-pocket costs.

Blood droplets icon

Patient brochure

Read about how Injectafer can help you get the iron you need.

Download

The information on this website should not take the place of talking with your healthcare professional. If you have any questions about your condition, or if you want more information about iron deficiency anemia, iron deficiency in heart failure, or Injectafer, talk to your healthcare professional. Only your healthcare professional can decide if Injectafer is right for you.

IMPORTANT SAFETY INFORMATION Expand

What is the most important information I should know about INJECTAFER?

INJECTAFER may cause serious side effects, including low blood phosphate levels (hypophosphatemia), which can be severe or serious and lead to hospitalization, softening of your bones (osteomalacia), and broken bones (fractures).

What is the most important information I should know about INJECTAFER?

INJECTAFER may cause serious side effects, including:

Low blood phosphate levels (hypophosphatemia)
Hypophosphatemia has happened after one or more doses of INJECTAFER and can be severe or serious, and lead to hospitalization, softening of your bones (osteomalacia), and broken bones (fractures). Hypophosphatemia can happen even if your blood phosphate levels were normal before treatment and you do not have any risk factors for hypophosphatemia. Your healthcare provider will check your blood phosphate levels before a repeat treatment with INJECTAFER if you are at risk for hypophosphatemia. If a repeat treatment is needed within 3 months of your last treatment, your healthcare provider will check your blood phosphate levels.

Tell your healthcare provider if you develop any of the following signs or symptoms of hypophosphatemia during treatment with INJECTAFER:

  • tiredness
  • muscle weakness or pain
  • bone or joint pain
  • broken bones

Your healthcare provider may permanently stop treatment with INJECTAFER if you develop severe hypophosphatemia with symptoms or if your blood phosphate levels remain low during treatment with INJECTAFER.

See “What are the possible side effects of INJECTAFER?” for more information about side effects.

What is INJECTAFER?

INJECTAFER is a prescription iron replacement medicine used for the treatment of:

  • iron deficiency anemia (IDA) in:
    • adults and children 1 year of age and older who cannot tolerate iron taken by mouth (oral) or who have not responded well to oral iron
    • adults who have chronic kidney disease who are not on dialysis (non-dialysis-dependent chronic kidney disease)
  • iron deficiency in adults with mild to moderate heart failure to improve the ability to exercise (improve exercise capacity)

It is not known if INJECTAFER is safe and effective in children with IDA who are under 1 year of age.

It is not known if INJECTAFER is safe and effective in children with iron deficiency and mild to moderate heart failure to improve exercise capacity.

Who should not receive INJECTAFER?

You should not receive INJECTAFER if you are allergic to ferric carboxymaltose or any of the other ingredients in INJECTAFER. The active ingredient in INJECTAFER is ferric carboxymaltose, the inactive ingredients are: water for injection, sodium hydroxide, or hydrochloric acid.

What should I tell my healthcare provider before receiving INJECTAFER?

Before receiving INJECTAFER, tell your healthcare provider about all of your medical conditions, including if you:

  • have a history of trouble absorbing certain vitamins or phosphate in your body
  • have inflammatory bowel disease
  • have hyperparathyroidism
  • have low vitamin D levels
  • have hereditary telangiectasia (HHT) or Osler-Weber-Rendu syndrome
  • have had an allergic reaction to iron given into your vein
  • have previously received INJECTAFER
  • have high blood pressure (hypertension)
  • are pregnant or plan to become pregnant. INJECTAFER may harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment with INJECTAFER
  • are breastfeeding or plan to breastfeed. INJECTAFER passes into your breast milk. It is not known if INJECTAFER will harm your baby. Talk to your healthcare provider about the best way to feed your baby during treatment with INJECTAFER

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive INJECTAFER?

  • INJECTAFER is given into your vein by intravenous (IV) infusion by your healthcare provider.
  • INJECTAFER is usually given in 2 doses at least 7 days apart for iron deficiency anemia or 6 weeks apart for iron deficiency with mild to moderate heart failure to improve exercise capacity.
  • If your healthcare provider decides it is right for you, INJECTAFER may be given intravenously by your healthcare provider as a single-dose treatment.
  • INJECTAFER treatment may be repeated if your healthcare provider decides it is needed.
  • INJECTAFER can cause discoloration or staining of your skin if leaking happens at your infusion site. Tell your healthcare provider if you notice any leaking from the infusion site during your infusion.

What are the possible side effects of INJECTAFER?

INJECTAFER may cause serious side effects, including:

  • See “What is the most important information I should know about INJECTAFER?”
  • Allergic reactions. Serious life-threatening allergic reactions that can lead to death have happened in people who receive INJECTAFER. Your healthcare provider will watch you during and for at least 30 minutes after you receive INJECTAFER. Tell your healthcare provider right away if you develop any of the following signs or symptoms of allergic reactions during or after treatment with INJECTAFER:
    • low blood pressure
    • feeling dizzy or lightheaded
    • loss of consciousness
    • trouble breathing
    • swelling
    • fast heartbeat
    • cold or clammy skin
    • feet or hands turn blue
    • itching
    • rash
    • hives
    • wheezing
  • High blood pressure. High blood pressure, sometimes with redness and warmth of the face (facial flushing), dizziness, or nausea, has happened during treatment with INJECTAFER. Your healthcare provider will check your blood pressure and check for any signs and symptoms of high blood pressure after you receive INJECTAFER.

The most common side effects of INJECTAFER include:

In adults:

  • nausea
  • high blood pressure
  • flushing
  • injection site reactions
  • skin redness
  • low blood phosphate levels
  • dizziness

In children:

  • low blood phosphate levels
  • injection site reactions
  • rash
  • headache
  • vomiting

This is the most important information to know about INJECTAFER, but not all the possible side effects. Call your doctor for medical advice about side effects.

You are encouraged to report Adverse Drug Events to American Regent, Inc.® at 1-800-734-9236 or to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.

Please see the Full Prescribing Information, including BOXED WARNING, for INJECTAFER.

REF-2888 2.0 8/2026

IMPORTANT SAFETY INFORMATION Expand

What is the most important information I should know about INJECTAFER?

INJECTAFER may cause serious side effects, including low blood phosphate levels (hypophosphatemia), which can be severe or serious and lead to hospitalization, softening of your bones (osteomalacia), and broken bones (fractures).

What is the most important information I should know about INJECTAFER?

INJECTAFER may cause serious side effects, including:

Low blood phosphate levels (hypophosphatemia)
Hypophosphatemia has happened after one or more doses of INJECTAFER and can be severe or serious, and lead to hospitalization, softening of your bones (osteomalacia), and broken bones (fractures). Hypophosphatemia can happen even if your blood phosphate levels were normal before treatment and you do not have any risk factors for hypophosphatemia. Your healthcare provider will check your blood phosphate levels before a repeat treatment with INJECTAFER if you are at risk for hypophosphatemia. If a repeat treatment is needed within 3 months of your last treatment, your healthcare provider will check your blood phosphate levels.

Tell your healthcare provider if you develop any of the following signs or symptoms of hypophosphatemia during treatment with INJECTAFER:

  • tiredness
  • muscle weakness or pain
  • bone or joint pain
  • broken bones

Your healthcare provider may permanently stop treatment with INJECTAFER if you develop severe hypophosphatemia with symptoms or if your blood phosphate levels remain low during treatment with INJECTAFER.

See “What are the possible side effects of INJECTAFER?” for more information about side effects.

What is INJECTAFER?

INJECTAFER is a prescription iron replacement medicine used for the treatment of:

  • iron deficiency anemia (IDA) in:
    • adults and children 1 year of age and older who cannot tolerate iron taken by mouth (oral) or who have not responded well to oral iron
    • adults who have chronic kidney disease who are not on dialysis (non-dialysis-dependent chronic kidney disease)
  • iron deficiency in adults with mild to moderate heart failure to improve the ability to exercise (improve exercise capacity)

It is not known if INJECTAFER is safe and effective in children with IDA who are under 1 year of age.

It is not known if INJECTAFER is safe and effective in children with iron deficiency and mild to moderate heart failure to improve exercise capacity.

Who should not receive INJECTAFER?

You should not receive INJECTAFER if you are allergic to ferric carboxymaltose or any of the other ingredients in INJECTAFER. The active ingredient in INJECTAFER is ferric carboxymaltose, the inactive ingredients are: water for injection, sodium hydroxide, or hydrochloric acid.

What should I tell my healthcare provider before receiving INJECTAFER?

Before receiving INJECTAFER, tell your healthcare provider about all of your medical conditions, including if you:

  • have a history of trouble absorbing certain vitamins or phosphate in your body
  • have inflammatory bowel disease
  • have hyperparathyroidism
  • have low vitamin D levels
  • have hereditary telangiectasia (HHT) or Osler-Weber-Rendu syndrome
  • have had an allergic reaction to iron given into your vein
  • have previously received INJECTAFER
  • have high blood pressure (hypertension)
  • are pregnant or plan to become pregnant. INJECTAFER may harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment with INJECTAFER
  • are breastfeeding or plan to breastfeed. INJECTAFER passes into your breast milk. It is not known if INJECTAFER will harm your baby. Talk to your healthcare provider about the best way to feed your baby during treatment with INJECTAFER

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive INJECTAFER?

  • INJECTAFER is given into your vein by intravenous (IV) infusion by your healthcare provider.
  • INJECTAFER is usually given in 2 doses at least 7 days apart for iron deficiency anemia or 6 weeks apart for iron deficiency with mild to moderate heart failure to improve exercise capacity.
  • If your healthcare provider decides it is right for you, INJECTAFER may be given intravenously by your healthcare provider as a single-dose treatment.
  • INJECTAFER treatment may be repeated if your healthcare provider decides it is needed.
  • INJECTAFER can cause discoloration or staining of your skin if leaking happens at your infusion site. Tell your healthcare provider if you notice any leaking from the infusion site during your infusion.

What are the possible side effects of INJECTAFER?

INJECTAFER may cause serious side effects, including:

  • See “What is the most important information I should know about INJECTAFER?”
  • Allergic reactions. Serious life-threatening allergic reactions that can lead to death have happened in people who receive INJECTAFER. Your healthcare provider will watch you during and for at least 30 minutes after you receive INJECTAFER. Tell your healthcare provider right away if you develop any of the following signs or symptoms of allergic reactions during or after treatment with INJECTAFER:
    • low blood pressure
    • feeling dizzy or lightheaded
    • loss of consciousness
    • trouble breathing
    • swelling
    • fast heartbeat
    • cold or clammy skin
    • feet or hands turn blue
    • itching
    • rash
    • hives
    • wheezing
  • High blood pressure. High blood pressure, sometimes with redness and warmth of the face (facial flushing), dizziness, or nausea, has happened during treatment with INJECTAFER. Your healthcare provider will check your blood pressure and check for any signs and symptoms of high blood pressure after you receive INJECTAFER.

The most common side effects of INJECTAFER include:

In adults:

  • nausea
  • high blood pressure
  • flushing
  • injection site reactions
  • skin redness
  • low blood phosphate levels
  • dizziness

In children:

  • low blood phosphate levels
  • injection site reactions
  • rash
  • headache
  • vomiting

This is the most important information to know about INJECTAFER, but not all the possible side effects. Call your doctor for medical advice about side effects.

You are encouraged to report Adverse Drug Events to American Regent, Inc.® at 1-800-734-9236 or to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.

Please see the Full Prescribing Information, including BOXED WARNING, for INJECTAFER.

REF-2888 2.0 8/2026

To contact us with questions or concerns about an American Regent product, please call us: 888-354-4855.

Injectafer® and the Injectafer® logo are trademarks of Vifor (International) Inc., Switzerland. Injectafer® is manufactured under license from Vifor (International) Inc., Switzerland. Trademarks not owned by American Regent, Inc. or Vifor (International) are the property of their respective owners.

This site is intended for US residents 18 years of age or older.

© 2026 American Regent, Inc. PP-IN-US-0247 (v2.0) 8/2026